Alerts & notifications

Highly potent synthetic opioid misrepresented as butonitazene

More highly potent nitazene variations have been identified.

Fake oxycodone tablets linked to serious harm

Fake oxycodone tablets, containing metonitazene, may be linked to a recent death and serious hospitalisations in New Zealand

Misrepresented MDMA linked to serious harm in Hawke’s Bay

UPDATED 11 August 2023
Serious harm has been linked with misrepresented MDMA in the Hawke’s Bay area.

Potent stimulant Alpha-PVP misrepresented as MDMA

An off-white powder being sold as MDMA in Auckland has been found to contain Alpha-PVP.

Synthetic cannabinoid harm in Christchurch linked to hospitalisations

A particularly dangerous batch of synthetic cannabinoids has been linked to serious harm in Christchurch in November 2022.

Yellow tablet/powder containing potent opioid likely to cause serious harm

UPDATED 28 MARCH 2023
Serious harm has been identified in relation to metonitazene found in a yellow powder. High Alert urges continued caution, particularly in the Auckland region.

Fentanyl in white powder causes multiple hospitalisations in Wairarapa region

UPDATED 1 JULY 2022
Fentanyl found in white powder linked to serious harm events in the Wairarapa region.

Highly potent opioid found in fake oxycodone tablets

A very potent opioid has been found in fake blue 30mg ‘M30’ oxycodone tablets being sold in the Wellington region.

New synthetic cathinone dimethylpentylone detected in NZ

The synthetic cathinone dimethylpentylone has been detected for the first time in New Zealand.

Synthetic cannabinoid harm in Taranaki

A particularly dangerous batch of synthetic cannabinoids is currently present in Taranaki.